Planning a sale, move, or exit before 2028? Book a 20-minute intro call →
Holding QSBS? Get a fixed-fee Section 1202 issue-spotting review →
Planning for Washington’s 9.9% income tax, effective January 1, 2028? Get the Tax Planning Guide →
Series A

Anti-Dilution Provisions: What Every Startup Founder Needs to Understand Before Their Series A

By Joe Wallin,

Published on Apr 9, 2026   —   15 min read

Term SheetsStartup LawFundraisingCap Table
Legal documents representing corporate formation

Summary

Anti-dilution provisions are among the most consequential — and least understood — terms in venture financing. Here's how they work, what they mean for your cap table, and what to negotiate.

Anti-dilution protection can materially change founder and employee ownership when a company issues securities below an existing preferred series’ conversion price. The key questions are what triggers an adjustment, how the conversion price changes, and which issuances the charter exempts.

In This Guide

A lower-priced financing can dilute existing holders through both new shares and an adjustment to preferred-stock conversion rights. Calculate those effects separately. A change in headline company valuation does not, by itself, tell you whether an adjustment occurs or how much ownership changes.

Here's what these provisions actually are, how they work, and what you need to negotiate before you sign your Series A term sheet.

What Anti-Dilution Protection Really Is

Issuing additional shares can reduce an existing holder’s outstanding-share percentage. For example, 500,000 of 1 million outstanding shares represents 50%; after another million shares are issued, the same holding represents 25%. An option grant is different from a share issuance, and may not change a fully diluted total that already includes the reserved pool. Always identify the denominator.

Price-based anti-dilution is a separate adjustment to the protected preferred stock’s conversion rights. The following example isolates that effect.

Suppose an investor buys Series A preferred at $10 per share and the company later sells new shares at $6. Depending on the charter and any waivers, the lower-priced issuance may reduce the Series A conversion price. A lower company valuation alone is not the contractual test, and differently priced securities may carry different rights.

Price-based anti-dilution reallocates some of the economic effect of a qualifying lower-priced issuance through conversion rights. It does not insure the investor against loss or preserve a fixed ownership percentage through future financings.

For common holders, the adjustment can reduce as-converted ownership even though their own share count stays the same. Investor protection and founder dilution are two sides of the calculation; neither determines actual exit proceeds without the liquidation terms.

The Two Main Types: Full Ratchet vs. Weighted Average

Full ratchet and weighted average use different methods to adjust the conversion price. Compare them using the same issuance assumptions.

Full Ratchet: Conversion Price Reset

Full ratchet generally reduces the protected series’ conversion price to the price of a qualifying lower-priced issuance, subject to the charter’s definitions, exceptions and any applicable floor. The size of the issuance does not moderate the adjustment the way it does under weighted-average protection.

If the original issue price and initial conversion price are both $10, and a qualifying $6 issuance resets the conversion price to $6, each Series A preferred share becomes convertible into approximately 1.6667 common shares. The preferred shares themselves have not been repurchased or reissued at a different historical price.

The additional as-converted shares can substantially dilute common stock. The existing investor does not have to contribute more money to receive the adjustment unless a separate pay-to-play provision or negotiated condition requires participation.

I'll give you a concrete example. Let's say you have a cap table that looks like this going into a down round:

Pre-Series B (Down Round Scenario):

  • Series A Investor: 1,000,000 shares at $10 per share ($10M investment)
  • Common Stock (you and employees): 2,000,000 shares
  • Total outstanding: 3,000,000 shares
  • Founders and employees combined: 66.7%
  • Series A ownership: 33.3%

When the qualifying Series B issuance occurs at $6 per share, the Series A conversion price falls from $10 to $6 under the assumed full-ratchet provision. For illustration, first isolate that conversion adjustment; the final ownership calculation must also include the Series B shares. The reset does not establish the market value of the existing preferred stock.

For this example, with no earlier adjustments: preferred shares held × original issue price ÷ adjusted conversion price = common shares issuable on conversion. This calculates an as-converted position, not additional preferred shares issued at the down-round closing.

Series A as-converted common shares: 1,000,000 × ($10 ÷ $6) = approximately 1,666,667. The number of Series A preferred shares remains 1,000,000.

The 1,000,000 Series A preferred shares now represent approximately 1,666,667 common shares on an as-converted basis. Ignoring the Series B shares solely to isolate this adjustment, common’s percentage falls from 66.7% to 54.5%. If the Series B raises $12 million at $6 per share and adds 2,000,000 shares, common’s actual post-round percentage is 2,000,000 ÷ 5,666,667, or approximately 35.3%. Existing investors’ purchases in Series B, if any, are separate.

That difference is why founders should model full ratchet before agreeing to it. Ask whether weighted-average protection, a floor, a sunset, narrower triggers or a negotiated waiver can address the investor’s concern with less dilution. Available leverage depends on the financing.

Weighted Average: Price and Issuance Size

Weighted-average protection accounts for the size of the qualifying issuance relative to a defined capitalization base. Compare its actual formula with full ratchet rather than assuming the label establishes either market prevalence or an acceptable economic result.

For a simplified cash issuance at one price, the formula can be expressed as follows. The charter’s definitions govern the capitalization base, consideration, and issued or deemed-issued shares; noncash transactions and convertible instruments require applying those definitions rather than substituting headline financing dollars.

New Conversion Price = Old Conversion Price × [(Outstanding Shares Before Round + (Investment Amount / Old Conversion Price)) / (Outstanding Shares Before Round + (Investment Amount / New Price))]

NCP = OCP × (A + B) ÷ (A + C). Here A is the capitalization base specified in the charter. In this single-price cash example, B is new investment divided by OCP, and C is the new shares issued. Because the new price is below OCP, B is smaller than C and the conversion price falls.

Broad-based and narrow-based weighted average differ in the securities counted in A, which appears in both the numerator and denominator. A broad base commonly includes outstanding common plus specified options and convertible securities on an as-converted basis. Narrow formulations count fewer securities; they do not universally mean preferred stock only. Read the charter to determine whether reserved but ungranted options, SAFEs, warrants and other instruments count.

Let me show you how this plays out with concrete numbers. Using the same scenario:

Pre-Series B Down Round (Same as Before):

  • Series A Investor: 1,000,000 shares at $10 per share ($10M investment)
  • Common Stock (you and employees): 2,000,000 shares
  • Total outstanding: 3,000,000 shares

Now Series B happens at $6 per share, and you're raising $12M. That means 2,000,000 new shares are issued at the Series B round.

Under broad-based weighted average, the formula is:

New Conversion Price = Old Conversion Price × (A + B) / (A + C)

For this example, A is 3,000,000: 2,000,000 common shares plus the 1,000,000 common shares initially issuable on conversion of Series A. There are no other securities or pool shares. B is the new cash divided by the old conversion price; C is the number of new shares issued. A different charter definition or capitalization changes the result.

The key insight is that B is always smaller than C in a down round (because the old price is higher, the same dollar amount buys fewer shares at the old price). This makes the fraction (A + B) / (A + C) less than 1, which pulls the conversion price downward.

Let’s plug in our numbers:

A = 3,000,000 (total shares outstanding before the round)

B = $12M / $10 = 1,200,000 (shares the new money would buy at the old Series A price)

C = $12M / $6 = 2,000,000 (shares actually issued in the Series B)

New Conversion Price = $10 × (3,000,000 + 1,200,000) / (3,000,000 + 2,000,000) = $10 × 4,200,000 / 5,000,000 = $10 × 0.84 = $8.40

So the Series A investor’s conversion price adjusts from $10 down to $8.40. They get some downward adjustment, but it’s far less aggressive than full ratchet. When their preferred shares eventually convert to common stock, they’ll convert at the new $8.40 price instead of $10, giving them approximately 1,190,476 common shares ($10M / $8.40) instead of the original 1,000,000—about 190,000 additional shares. Under full ratchet, by comparison, they’d have gotten roughly 667,000 additional shares.

In this example, after including the 2,000,000 Series B shares, common holds approximately 38.53% under weighted average, compared with 40% without an adjustment and 35.29% under full ratchet. That comparison measures this financing, not a universal ceiling. A larger issuance, lower price, or narrower base can make weighted-average dilution substantial.

A smaller A generally produces a larger conversion-price reduction for the same financing. Labels alone are insufficient: use the actual definition of outstanding or deemed-outstanding shares when comparing two proposed formulas.

Ask for broad-based weighted average and a clear definition of A. Model the proposed language rather than assuming the term-sheet label resolves the treatment of every security.

What Triggers Anti-Dilution? Understanding Down Rounds

A typical price-based provision applies when the company issues, or is deemed to issue, additional common shares for consideration below the protected series’ then-current conversion price. The charter defines those terms and the exceptions.

  • New financing: A lower price per share can trigger protection. A lower headline valuation is not itself the trigger.
  • Secondary sales: An ordinary transfer between stockholders is generally not a company issuance. A transaction containing a company issuance or special contractual rights needs separate review.
  • Options, warrants, notes and SAFEs: Deemed-issuance rules can apply when an instrument is issued or its terms change. Later exercise or conversion may be excluded to avoid counting the same issuance twice. Terms fixed at inception are not a universal exemption.
  • Employee and service-provider equity: Check the charter’s exemption, plan coverage and required board or preferred approvals. A 409A valuation addresses tax pricing; it does not itself create an anti-dilution exemption.
  • Acquisitions and strategic transactions: Check the specific exemption, its limits and required approvals.
  • Stock splits and similar events: These commonly receive separate proportional conversion adjustments, rather than the down-round formula.

For a concrete example of definitions, exemptions, deemed issuances and a weighted-average formula, see §§4.4.1–4.4.4 of this publicly filed certificate of incorporation. It illustrates one charter; the signed charter for your company controls.

Pay-to-Play and Anti-Dilution: How They Interact

Pay-to-play conditions specified investor rights on meeting a future financing participation requirement. The required investment and the consequence of failing to participate come from the documents; they need not equal the investor’s existing ownership percentage. Losing anti-dilution protection is one possible consequence.

Here's the logic from the investor's perspective: "We invested at $10 per share in Series A. If Series B is at $6 per share and we don't participate, why should we get anti-dilution protection? We're not backing the company at the lower price."

Pay-to-play changes the financing incentives and consequences of nonparticipation. Model which investors satisfy the requirement and what happens to each remaining position. An investor’s inability or decision not to participate does not necessarily reflect its view of the company, and the provision does not guarantee a better financing outcome for common holders.

A pay-to-play provision can remove anti-dilution protection, convert preferred to common, or impose another consequence when an investor does not meet the specified participation requirement. Read the participation threshold, exceptions and remedy; do not assume the requirement equals the investor’s ownership percentage.

How Anti-Dilution Appears in Your Actual Charter

A term-sheet summary such as “broad-based weighted average” leaves important details unresolved. The operative language must specify the formula, share-count base, covered issuances, exceptions, and approvals. The following sentence is an illustrative paraphrase, not a quotation from a particular charter:

"In the event the Company issues shares at a price below the Conversion Price, the Conversion Price shall be adjusted to equal the product of the Conversion Price then in effect multiplied by a fraction..."

Compare the charter’s formula and definitions with the term sheet before approving the financing documents.

Read the term sheet’s binding-effect language and the definitive documents. Preferred-stock conversion rights for a Delaware corporation are established through the charter or an authorized designation, but separate agreements can create contractual obligations. Do not assume the charter is the only document capable of creating an enforceable anti-dilution-related commitment. DGCL §151

Resolve any mismatch before closing. Later changes may require board, stockholder and class or series approvals, as well as any contractual consents.

Negotiating Anti-Dilution: What Founders Can Actually Push Back On

The availability and scope of anti-dilution protection are negotiated. Evaluate the requested formula, exemptions, duration, waiver mechanism, and financing alternatives without assuming that one investor category always demands protection or another will omit it.

These are the things you should push for:

Weighted average instead of full ratchet: Make the conversion formula a priority. Show the investor the cap-table consequences of each alternative and discuss whether a narrower provision addresses the concern. Evaluate an insistence on full ratchet in the context of the complete financing and your alternatives.

The company’s alternatives, cash runway and investor leverage affect what can be negotiated. Full ratchet deserves careful modeling regardless of the investor’s sophistication.

Broad-based rather than narrow-based: Negotiate the exact securities included in A. A larger base ordinarily moderates the adjustment for a given financing; quantify the difference under the proposed definitions.

Strong carve-outs: Seek a clear exemption for employee, director and service-provider grants under the approved plan, with workable approval requirements. Coordinate tax valuation separately. An independent 409A valuation is not a universal contractual prerequisite to the exemption.

Clarity on the trigger: Compare the consideration per share determined under the charter with the protected series’ then-current conversion price. A discount to a financing price or a price below fair market value does not, by itself, establish that comparison. Apply the deemed-issuance rules and exemptions to notes and warrants.

Define the capitalization base A precisely. A appears in both the numerator and denominator of (A + B) ÷ (A + C). Holding B and C fixed with B less than C, increasing A moves that fraction toward one and moderates the conversion-price reduction. Specify which issued, reserved, and convertible positions count.

These are useful negotiation points. Their availability depends on the financing, investor requirements and the company’s alternatives.

The parties can also negotiate limits, thresholds, duration, waivers or the removal of protection. Some alternatives may be commercially unavailable in a particular round. Assess the actual proposal rather than assuming the charter must follow one fixed pattern.

Prioritize the provisions with the greatest modeled effect. The investor’s willingness to change them depends on the actual financing; no list of negotiation points guarantees flexibility.

How Anti-Dilution Actually Affects Your Cap Table in a Down Round

Here's what a real down round looks like with anti-dilution. This is the scenario every founder should model before they sign a Series A term sheet.

Original Cap Table (at Series A close):

  • Founder/Employees (Common): 5,000,000 shares
  • Series A Investor: 2,500,000 shares at $10/share ($25M investment)
  • Total outstanding: 7,500,000 shares
  • Founders and employees combined: 66.7%
  • Series A ownership: 33.3%

Series B Down Round, 2 Years Later at $6/share (Weighted Average, Broad-Based):

You're raising $30M at $6/share. That's 5,000,000 new shares.

Using the same broad-based weighted average formula from earlier:

A = 7,500,000 (total shares outstanding before the round)

B = $30M / $10 = 3,000,000 (shares the new money would buy at the old Series A price)

C = $30M / $6 = 5,000,000 (shares actually issued in the Series B)

New Conversion Price = $10 × (7,500,000 + 3,000,000) / (7,500,000 + 5,000,000) = $10 × 10,500,000 / 12,500,000 = $10 × 0.84 = $8.40

So the Series A investor’s conversion price drops from $10 to $8.40. When their preferred shares convert to common, they’ll receive $25M / $8.40 = approximately 2,976,190 common shares instead of the original 2,500,000—about 476,190 additional shares from the anti-dilution adjustment.

Series B investor invests $30M at $6/share and gets 5,000,000 new shares.

Post-Series B Cap Table:

  • Founder/Employees (Common): 5,000,000 shares
  • Series A (at $8.40 conversion price): approximately 2,976,190 shares on an as-converted basis
  • Series B: 5,000,000 shares at $6/share ($30M investment)
  • Total on as-converted basis: approximately 12,976,190 shares
  • Founders and employees combined: approximately 38.5%
  • Series A ownership: approximately 22.9%
  • Series B ownership: approximately 38.5%

Common’s ownership falls from 66.7% to approximately 38.5%. Without the anti-dilution adjustment it would be 5,000,000 ÷ 12,500,000 = 40%. The adjustment therefore costs about 1.47 percentage points beyond the new-share dilution. Whether that cost is acceptable depends on the financing and exit scenarios.

Under full ratchet in this example, Series A converts into approximately 4,166,667 common shares ($25M ÷ $6). Total as-converted shares are approximately 14,166,667. Founders and employees together hold approximately 35.3%, compared with 38.5% under weighted average. These figures describe the combined common-stock position, not any individual founder’s ownership.

The Relationship Between Anti-Dilution and Liquidation Preferences

Anti-dilution changes conversion rights; liquidation preferences determine how proceeds are distributed. Model both together.

Liquidation preferences determine how sale or liquidation proceeds are distributed. With 1x nonparticipating preferred, an investor generally receives the preference or the amount payable on conversion to common, whichever is greater under the charter. Taking the preference does not also entitle that investor to share in the common-stock residual.

A typical price-based anti-dilution adjustment changes the conversion ratio, not the original investment amount used for a fixed 1x preference. It can make conversion preferable at a lower exit value. Participating preferred can also receive a larger as-converted share of residual proceeds, subject to the charter and any cap.

If a nonparticipating investor takes its fixed preference, the anti-dilution adjustment does not, by itself, give that investor a second claim on the remaining proceeds. Common can still receive little or nothing because of preferences, seniority and the exit value. Model the actual waterfall, including each series’ conversion choice, rather than multiplying a fully diluted percentage by the residual.

This is why modeling down-round scenarios before you sign a Series A is crucial. You need to understand not just how anti-dilution affects your percentage ownership, but how it affects your actual proceeds in various exit scenarios.

Common Mistakes Founders Make with Anti-Dilution

The same mistakes recur, and they're preventable.

Not reading the actual charter language: You negotiate on the term sheet and then sign the charter without comparing the two. The charter language should match the term sheet, but gaps happen. Read your charter before you sign. Have your lawyer walk you through it.

Not modeling down-round scenarios. Specify the new price per share, cash raised, capitalization base and other securities. Calculate new-share dilution and the conversion adjustment separately, then model dollar exit proceeds under the liquidation waterfall. A percentage change in headline valuation is not enough.

Accepting full ratchet without modeling it. Compare its effect with the proposed weighted-average alternative, including a small lower-priced issuance. Assess the terms and available financing alternatives before committing.

Confusing anti-dilution with dilution from new fundraising: Some founders think anti-dilution somehow prevents normal dilution from new rounds. It doesn't. You're still going to get diluted when you raise Series B and Series C. Anti-dilution is an adjustment on top of that. The two are separate phenomena.

Not checking exemptions. Before a grant or other issuance, confirm the charter’s exemption and required approvals. Apply the deemed-issuance rules to options and convertible securities; do not assume their later exercise or conversion creates a second adjustment.

How to Evaluate the Proposed Terms

Use model documents as a reference point, then evaluate the actual bargain: the formula, its share-count definition, exceptions, waiver rights, pay-to-play conditions and the company’s financing alternatives. The NVCA model financing documents are a useful starting point. They are not evidence that every current financing uses the same terms.

A full-ratchet provision can be costly even in a small financing. Weighted-average protection can also produce substantial dilution if the round is large or the base is narrow. Ask for a side-by-side cap table and exit waterfall under the actual proposed language.

Practical Advice: What to Negotiate and What to Accept

Here's my practical playbook for founders dealing with anti-dilution in a Series A term sheet:

  • Start with broad-based weighted average. Specify which shares and instruments count in A, and compare the result with the alternatives using the same financing assumptions.
  • Quantify a narrow base. It may produce a materially larger adjustment. Decide whether the complete deal is acceptable after modeling the actual definition; the label alone does not determine the answer.

Quantify full ratchet before agreeing to it. A small qualifying issuance can produce a large conversion adjustment. Discuss narrower triggers, weighted average, a floor, a sunset, or other negotiated limits; an insistence on one term does not by itself establish the investor’s character.

  • Negotiate workable carve-outs. Cover anticipated service-provider grants and ordinary business transactions, with clear approval requirements. Check each proposed issuance against the signed charter.

Get clarity on triggering events. Work through issuance, amendment and conversion of notes or SAFEs, option and warrant grants, and strategic issuances. Identify when the charter treats shares as issued, how consideration is calculated, and whether an exemption or prior adjustment applies. Record the conclusions.

Model several financing prices and amounts using the agreed capitalization definition. State whether valuation inputs are pre-money or post-money and account for pool changes and convertible instruments. Compare ownership and dollar exit proceeds with and without the adjustment.

Assess the proposed protection alongside the financing’s price, cash runway, governance and liquidation terms. Decide which changes matter most using the modeled results and available alternatives.

Final Thoughts

Evaluate anti-dilution alongside price, cash raised, governance, liquidation rights, and financing alternatives. Their relative importance depends on the proposed deal and the company’s needs.

The key is understanding what you're agreeing to before you sign. Read the term sheet language carefully. Have a lawyer explain how weighted average actually works with your specific numbers. Model a down-round scenario. Ask questions about carve-outs. And then make informed decisions about what to negotiate and what to accept.

Anti-dilution is just one protection in an investor's toolkit, but it's a powerful one. Make sure you understand it before you hand it over.


Negotiating a round? book a 20-minute call with Joe Wallin or email wallin@carneylaw.com to talk through the terms before documents go out.


Navigating anti-dilution, liquidation preferences, and cap table mechanics is something every founder should understand before signing a Series A term sheet. If you want a second set of eyes on your deal terms, reach out — this is exactly the kind of work I do.


Related: QSBS pillar

Technical review: September 10, 2026. Examples assume no other securities, exemptions or adjustments unless stated. Share counts are rounded for illustration. Actual charter terms control.

Share on Facebook Share on Linkedin Share on Twitter Send by email

Subscribe to the newsletter

Subscribe to the newsletter for the latest news and work updates straight to your inbox, every week.

Subscribe